Like Elon Musk or not, he's trolling the shit out of Liawatha....
The person that created this meme is a master.
Here's the image if you want to share:
Like Elon Musk or not, he's trolling the shit out of Liawatha....
The person that created this meme is a master.
Here's the image if you want to share:
I don't remember learning about this back when I was in school.
Mercator Projection mapping inflates the sizes of land masses away from the equator.
Here's an interesting article about the misconceptions of the Mercator map
and on this website, you can type in the name of a country and drag and drop it to compare
the size of it to other countries.
The other day I was out running errands and this song came on.....
You do realize you're singing it now..............
Renay Mandel Corren
El Paso, TX—A plus-sized Jewish lady redneck died in El Paso on Saturday.
Of itself hardly news, or good news if you're the type that subscribes to the notion that anybody not named you dying in El Paso, Texas is good news. In which case have I got news for you: the bawdy, fertile, redheaded matriarch of a sprawling Jewish-Mexican-Redneck American family has kicked it.
Big Country left a comment reaching out and asking for support.
Here is an explanation of Mike's situation:
BC has set up a go fund me that can be accessed here:
Irish
CAMBRIDGE, Mass. — At first glance, Moderna Therapeutics looks like the most enviable biotech startup in the world. It has smashed fundraising records and teamed up with pharmaceutical giants as it pursues a radical plan to revolutionize medicine by transforming human cells into drug factories.
But the reality is more complicated.
A STAT investigation found that the company’s caustic work environment has for years driven away top talent and that behind its obsession with secrecy, there are signs Moderna has run into roadblocks with its most ambitious projects.
/snip
The company has published no data supporting its vaunted technology, and it’s so secretive that some job candidates have to sign nondisclosure agreements before they come in to interview. Outside venture capitalists said Moderna has so many investors clamoring to get in that it can afford to turn away any who ask too many questions. Some small players have been given only a peek at Moderna’s data before committing millions to the company, according to people familiar with the matter.
“It’s a case of the emperor’s new clothes,” said a former Moderna scientist. “They’re running an investment firm, and then hopefully it also develops a drug that’s successful.”
/snip
Moderna’s technology promised to subvert the whole field, creating therapeutic proteins inside the body instead of in manufacturing plants. The key: harnessing messenger RNA, or mRNA.
In nature, mRNA molecules function like recipe books, directing cellular machinery to make specific proteins. Moderna believes it can play that system to its advantage by using synthetic mRNA to compel cells to produce whichever proteins it chooses. In effect, the mRNA would turn cells into tiny drug factories.
It’s highly risky. Big pharma companies had tried similar work and abandoned it because it’s exceedingly hard to get RNA into cells without triggering nasty side effects. But if Moderna can get it to work, the process could be used to treat scores of diseases, including cancers and rare diseases that can be death sentences for children.